Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02997085 · ClinicalTrials.gov registry record · NA

Virtual Reality for Pain Management Study

A NA study of Pain, Acute, sponsored by University of Texas at Austin.

Completed
Registry status
NA
Development phase
103
Enrollment target
1
Study location

NCT02997085: Completed NA study of Pain, Acute, sponsored by University of Texas at Austin.

NCT02997085 is a NA study of Pain, Acute that has completed, run by University of Texas at Austin. The registered enrollment target is 103 participants, roughly in line with the 98-participant average among 31 other Pain, Acute trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02997085, a NA study of Pain, Acute, has completed, sponsored by University of Texas at Austin.

COMPLETED
Registry status
NA
Development phase
103 participants
Enrollment target
1
Study location

Study Summary

Virtual Reality (VR) is one non-pharmacological method that has shown promise as an effective means of decreasing pain levels following treatment, and for significant periods of time. Additionally, neurobiology studies of VR have demonstrated a decrease in brain activity associated with pain. While VR is clearly a promising, drug-free option for pain treatment, existing VR systems are expensive and use unconvincing graphics. Recent advances in VR technology (i.e., improved realism and immersion using 360-degree 3D technology and more affordable delivery systems) allow the development of more realistic and more cost-effective applications. Capitalizing on these advances and the investigators' experiences with VR intervention development and evaluation, the current study will test a state-of-the-art VR experience in pain management intervention (Live-Action 360° Video Virtual Reality(VVR)) and compare it to established standard computer generated imagery (CGI) 360° VVR content for pain management intervention in a medical setting. The participant's participation will help the investigators determine which VR intervention is most effective in reducing acute pain in hospital patients.

Primary Outcome

The Pain Questionnaire was used to assess the participant's pain prior to receiving VR treatment, following VR treatment, and at the ten-minute follow-up assessment. It was derived from the Brief Pain Inventory (BPI) and contains the Numerical Rating Scales (NRS) to assess the participant's pain as outlined by recommendations for outcome measures in clinical pain trials.The NRS was also chosen because it could be administered orally if patients could not use their hands to write or use the iPad.

Conditions Studied

Interventions

  • DEVICE Live-Action 360° Video Virtual Reality
  • DEVICE CGI 360° Video Virtual Reality

Study Locations (1)

Texas

  • University of Texas at Austin - Austin

Trial Details

FieldValue
Enrollment Target 103 participants
Start Date 2017-01
Est. Completion 2018-07
Phase NA
University of Texas at Austin

257 total trials

What the finished NCT02997085 record still lists

NCT02997085 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 98-participant average among 31 other Pain, Acute trials with a reported enrollment target.

The record links to 1 condition, with Pain, Acute appearing as the primary indexed condition, and to 2 interventions - of which Live-Action 360° Video Virtual Reality is the first listed.

NCT02997085 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT02997085 about?

NCT02997085 is a clinical study titled "Virtual Reality for Pain Management Study". Virtual Reality (VR) is one non-pharmacological method that has shown promise as an effective means of decreasing pain levels following treatment, and for significant periods of time. Additionally, neurobiology studies of VR have demonstrated a decrease in brain activity associated with pain. While ...

What is the current status of trial NCT02997085?

This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2017-01. Estimated completion is 2018-07.

What conditions does trial NCT02997085 study?

This clinical trial studies the following conditions: Pain, Acute.

What interventions are being tested in trial NCT02997085?

The interventions under investigation include: Live-Action 360° Video Virtual Reality (DEVICE), CGI 360° Video Virtual Reality (DEVICE).

Who is sponsoring clinical trial NCT02997085?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02997085 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Acute

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02997085's enrollment target sits among peer trials

103 13th of 31 higher than 19 of 31 other Pain, Acute trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain, Acute trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04690348 · 103 participants · Phase 2

    Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study

  • NCT05282277 · 103 participants · Phase 4

    Examining the Effects of Estradiol on Neural and Molecular Response to Reward

  • NCT05566769 · 103 participants · NA

    Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

  • NCT05834478 · 103 participants · Phase 3

    Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02997085, the US trial registry maintained by the National Library of Medicine. NCT02997085 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.